---
title: "Crop Life Science Ltd (CLSL) — Share Price, Financials & Analysis"
symbol: "CLSL"
company: "Crop Life Science Ltd"
canonical: "https://tapetide.com/stocks/CLSL"
isin: "INE00NH01017"
nse_symbol: "CLSL"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 142.26
generated_at: "2026-09-13T18:57:11.153Z"
---

# Crop Life Science Ltd (CLSL)

Canonical page: https://tapetide.com/stocks/CLSL

## Company

- **NSE Symbol:** CLSL
- **ISIN:** INE00NH01017
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2023-08-30
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** croplifescience.com

## About

Incorporated in 2006, Crop Life Sciences 
Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]

## Latest Price

- **Price:** ₹83
- **Change:** -4.25 (-4.87%)
- **Open:** ₹82.95
- **Day High:** ₹83
- **Day Low:** ₹82.95
- **Previous Close:** ₹87.25
- **Volume:** 6000
- **As Of:** 2026-09-07T09:59:51+00:00

## Key Fundamentals

Observed at 2026-09-11T04:39:14.757364Z.

- **Market Cap:** ₹142.26 Cr
- **Classification:** SME
- **P/E (reported):** 21.9
- **Book Value:** ₹49.15
- **Price to Book:** 1.69
- **Dividend Yield:** 0%
- **ROE:** 7.38%
- **ROCE:** 15.58%
- **Debt to Equity:** 0.67
- **Revenue (yearly):** ₹208.9 Cr
- **Net Income:** ₹6.5 Cr
- **EBITDA:** ₹19.5 Cr
- **52-Week High:** ₹92.25
- **52-Week Low:** ₹39.05
- **RSI (14):** 56.94

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 32.53 | 9% |
| growth | 39.23 | 9% |
| momentum | 98.9 | 12% |
| ownership | 50 | 24% |
| quality | 51.5 | 22% |
| valuation | 40.24 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.02% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -408.67% | 8.4% | -67.69% |
| ebitda margin growth | 8.46% | 27.52% | — |
| net income growth | 16.07% | 19% | 14% |
| revenue growth | 3.62% | 16% | 14% |
| roce | 10.42% | 17.85% | — |
| roe | 7.11% | 7.4% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 79 | 52 | 97 | 101 | 106 | 94 | 120 | 87 |
| Expenses | 75 | 45 | 91 | 95 | 98 | 87 | 112 | 78 |
| Operating Profit | 5 | 7 | 6 | 6 | 8 | 8 | 8 | 9 |
| OPM % | 6 | 13 | 7 | 6 | 8 | 8 | 7 | 10 |
| Other Income | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Interest | 1 | 2 | 1 | 2 | 2 | 2 | 3 | 3 |
| Depreciation | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 2 | 3 | 4 | 4 | 4 | 5 | 4 | 6 |
| Tax % | 62 | -1 | 20 | 32 | 23 | 30 | 26 | 32 |
| Net Profit | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| EPS in Rs | 0.78 | 2.61 | 1.96 | 1.56 | 2.01 | 1.86 | 1.88 | 2.19 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 126 | 107 | 94 | 130 | 191 | 196 | 203 |
| Expenses | 118 | 98 | 86 | 118 | 178 | 180 | 186 |
| Operating Profit | 8 | 9 | 8 | 12 | 13 | 16 | 17 |
| OPM % | 7 | 8 | 8 | 9 | 7 | 8 | 8 |
| Other Income | 0 | 1 | 0 | 1 | 2 | 1 | 2 |
| Interest | 2 | 2 | 2 | 3 | 3 | 5 | 5 |
| Depreciation | 2 | 3 | 2 | 4 | 3 | 3 | 3 |
| Profit before tax | 5 | 5 | 4 | 6 | 8 | 9 | 10 |
| Tax % | 30 | 25 | 25 | 27 | 26 | 26 | 29 |
| Net Profit | 3 | 4 | 3 | 4 | 6 | 7 | 7 |
| EPS in Rs | 2.69 | 3.08 | 2.34 | 3.39 | 3.52 | 3.86 | 4.08 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 12 | 12 | 12 | 12 | 17 | 17 | 17 |
| Reserves | 18 | 21 | 24 | 29 | 55 | 61 | 68 |
| Borrowings | 16 | 18 | 22 | 27 | 34 | 44 | 57 |
| Other Liabilities | 31 | 35 | 37 | 34 | 67 | 55 | 63 |
| Total Liabilities | 76 | 86 | 95 | 102 | 172 | 178 | 205 |
| Fixed Assets | 12 | 13 | 11 | 16 | 22 | 22 | 16 |
| CWIP | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 12 | 13 | 13 |
| Other Assets | 64 | 73 | 82 | 86 | 138 | 142 | 177 |
| Total Assets | 76 | 86 | 95 | 102 | 172 | 178 | 205 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | 4 | 0 | 2 | -8 | -2 | -8 |
| Cash from Investing Activity | -1 | -2 | -2 | -4 | -16 | -4 | 2 |
| Cash from Financing Activity | -3 | -1 | 1 | 1 | 24 | -5 | -9 |
| Net Cash Flow | -1 | 1 | -1 | -2 | 0 | -11 | -15 |
| Free Cash Flow | 2 | 1 | -2 | -3 | -13 | -5 | -4 |
| CFO/OP | 46 | 58 | 11 | 34 | -49 | 3 | -31 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 80 | 89 | 143 | 92 | 148 | 129 | 134 |
| Inventory Days | 93 | 159 | 137 | 104 | 99 | 126 | 170 |
| Days Payable | 72 | 108 | 137 | 79 | 131 | 113 | 127 |
| Cash Conversion Cycle | 100 | 140 | 143 | 116 | 117 | 141 | 177 |
| Working Capital Days | 50 | 74 | 93 | 86 | 86 | 89 | 105 |
| ROCE % | — | 14 | 11 | 14 | 13 | 12 | 12 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 70.01% | 70.01% | 70.01% | 70.01% | 70.01% | 70.01% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 25.65% | 25.73% | 24.43% | 23.75% | 23.84% | 23.3% |
| Others | 4.34% | 4.26% | 5.55% | 6.24% | 6.15% | 6.69% |
| No. of Shareholders | 2064 | 1858 | 1602 | 1465 | 1219 | 1060 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 5 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 87.44 | Sell |
| EMA (10) | 85.21 | Sell |
| SMA (20) | 82.14 | Buy |
| EMA (20) | 81.41 | Buy |
| SMA (50) | 66.73 | Buy |
| EMA (50) | 70.51 | Buy |
| SMA (100) | 55.72 | Buy |
| EMA (100) | 62.02 | Buy |
| SMA (200) | 54.34 | Buy |
| EMA (200) | 56.52 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 56.94 | Neutral |
| MACD (12,26,9) | 5.77 | Sell |
| Stochastic (14,3,3) | 58.17 | Neutral |
| ADX (14) | 56.82 | Buy |
| Williams %R (14) | -51.68 | Neutral |
| ATR (14) | 4.17 | High Volatility |
| ROC (12) | 4.53 | Buy |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 61.27 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 May 2026 - Annual Secretarial Compliance Report not applicable for year ended 31 March 2026 under Regulation 15(2) exemption. | [Updates 8 May 2026 - Annual Secretarial Compliance Report not applicable for year ended 31 March 2026 under Regulation 15(2) exemption.](https://nsearchives.nseindia.com/corporate/CROPLIFE_08052026154215_AnnualSecretarialComplianceReport.pdf) |
| 4 Sep - Letters sent to non-email shareholders; 20th AGM on 23 Sep 2026 via VC/OAVM. | [General Updates 4 Sep - Letters sent to non-email shareholders; 20th AGM on 23 Sep 2026 via VC/OAVM.](https://nsearchives.nseindia.com/corporate/CROPLIFE_04092026145303_Draftletterforannualreportlink.pdf) |
| 4 July 2026 - Promoters disclosed on-market sales on 2 July 2026; holdings reduced for three family members. | [Updates 4 July 2026 - Promoters disclosed on-market sales on 2 July 2026; holdings reduced for three family members.](https://nsearchives.nseindia.com/corporate/CROPLIFE_04072026170910_PITDISCLOSUREFINAL.pdf) |
| 4 July 2026 - Promoter group sold 4,80,000 shares, 2.81%, on open market July 2, 2026. | [Updates 4 July 2026 - Promoter group sold 4,80,000 shares, 2.81%, on open market July 2, 2026.](https://nsearchives.nseindia.com/corporate/CROPLIFE_04072026171809_DisclosureunderReg292.pdf) |
| 4 July 2026 - Promoter group disclosed 4,80,000-share market transaction on 02 July 2026; Whole-time Director bought 4,80,000 shares. | [Updates 4 July 2026 - Promoter group disclosed 4,80,000-share market transaction on 02 July 2026; Whole-time Director bought 4,80,000 shares.](https://nsearchives.nseindia.com/corporate/CROPLIFE_04072026171431_FormBSEBIPITFINAL.pdf) |
| 30 Jul - Mr. Pareshbhai Bhagvanbhai Parsana appointed Additional Independent Director for five years from July 30, 2026. | [Appointment 30 Jul - Mr. Pareshbhai Bhagvanbhai Parsana appointed Additional Independent Director for five years from July 30, 2026.](https://nsearchives.nseindia.com/corporate/CROPLIFE_30072026170322_Reg30PareshBhai.pdf) |
| 30 Jul - Mr. Alpeshbhai Gordhanbhai Vaghasiya appointed Additional Independent Director for five years from July 30, 2026. | [Appointment 30 Jul - Mr. Alpeshbhai Gordhanbhai Vaghasiya appointed Additional Independent Director for five years from July 30, 2026.](https://nsearchives.nseindia.com/corporate/CROPLIFE_30072026165938_Reg30AlpeshBhai.pdf) |
| 30 Jul - Board approved M/s. Y. S. Thakar & Co. as cost auditor for FY 2026-27. | [Appointment 30 Jul - Board approved M/s. Y. S. Thakar & Co. as cost auditor for FY 2026-27.](https://nsearchives.nseindia.com/corporate/CROPLIFE_30072026170836_Regulation30AppointmentofCostAuditor.pdf) |
| 30 Jul - Board appointed two independent directors and named cost and internal auditors for FY27. | [Outcome of Board Meeting 30 Jul - Board appointed two independent directors and named cost and internal auditors for FY27.](https://nsearchives.nseindia.com/corporate/CROPLIFE_30072026165434_Outcome.pdf) |
| 30 Jul - Board appointed M/s A R Shaikh & Co as internal auditor for FY2026-27 on July 30, 2026. | [Appointment 30 Jul - Board appointed M/s A R Shaikh & Co as internal auditor for FY2026-27 on July 30, 2026.](https://nsearchives.nseindia.com/corporate/CROPLIFE_30072026171231_Regulation30AppointmentofInternalAuditors.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_30642_CLSL_2025_2026_A_11601517_26082026124544.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27825_CLSL_2024_2025_A_5718159_28082025174532.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25197_CLSL_2023_2024_2708202419439.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23964_CLSL_2022_2023_21112023190315_11212023200000.zip) |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3152_WINSOME_2012_2013_21012014091130.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/987cdb84-be57-472c-b069-b3f5c8b39d1e.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1375f32d-e420-49b2-ba7f-25a16c01d1eb.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/351b0aaf-b524-4b71-8ae9-b64806031abc.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/514348/77138514348.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/514348/72548514348.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:11.153Z.